Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Anjarium Biosciences

Anjarium Biosciences

Series A
Schlieren, SwitzerlandSep 2021
Healthtech

Anjarium Biosciences raised €51M in a Series A round in Sep 2021. The company is based in Schlieren, Switzerland. Investors in the round: Abingworth LLP, GIMV, Omega Funds and 2 others. Data as of Nov 2026.

← Anjarium Biosciences
Amount raised
€51M
€50,982,914
Native amount
55,500,000 CHF
Stage
Series A
series a
Investors
5

Provenance & confidence

High confidence
Amount
55,500,000 CHF
ECB-at-date → €51M · rate 1.0886 on 2021-09-16
High confidence
Source

startupticker.ch · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

5 named
Abingworth LLPGIMVOmega FundsPfizer VenturesSurveyor Capital
Date
Sep 2021
Round type
series a
Amount (EUR)
€51M

Other rounds

same company

This is the company's only recorded round.

Related news